Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial

医学 血压 溶栓 随机对照试验 冲程(发动机) 内科学 外科 麻醉 心肌梗塞 机械工程 工程类
作者
Mikaël Mazighi,Sébastien Richard,Bertrand Lapergue,Igor Sibon,Benjamin Gory,Jérôme Berge,Arturo Consoli,Julien Labreuche,Jean‐Marc Olivot,Joseph P. Broderick,Alain Duhamel,Emmanuel Touzé,Adnan Iqbal Qureshi,Amélie Yavchitz,Simon Escalard,Jean‐Philippe Désilles,Hocine Redjem,Stanislas Smajda,Robert Fahed,Solène Hébert
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:20 (4): 265-274 被引量:238
标识
DOI:10.1016/s1474-4422(20)30483-x
摘要

High systolic blood pressure after successful endovascular therapy for acute ischaemic stroke is associated with increased risk of intraparenchymal haemorrhage. However, no randomised controlled trials are available to guide optimal management. We therefore aimed to assess whether an intensive systolic blood pressure target resulted in reduced rates of intraparenchymal haemorrhage compared with a standard systolic blood pressure target.We did a multicentre, open-label, randomised controlled trial at four academic hospital centres in France. Eligible individuals were adults (aged ≥18 years) with an acute ischaemic stroke due to a large-vessel occlusion that was successfully treated with endovascular therapy. Patients were randomly assigned (1:1) to either an intensive systolic blood pressure target group (100-129 mm Hg) or a standard care systolic blood pressure target group (130-185 mm Hg), by means of a central web-based procedure, stratified by centre and intravenous thrombolysis use before endovascular therapy. In both groups, the target systolic blood pressure had to be achieved within 1 h after randomisation and maintained for 24 h with intravenous blood pressure lowering treatments. The primary outcome was the rate of radiographic intraparenchymal haemorrhage at 24-36 h and the primary safety outcome was the occurrence of hypotension. Analyses were done on an intention-to-treat basis. BP-TARGET is registered with ClinicalTrials.gov, number NCT03160677, and the trial is closed at all participating sites.Between June 21, 2017, and Sept 27, 2019, 324 patients were enrolled in the four participating stroke centres: 162 patients were randomly assigned to the intensive target group and 162 to the standard target group. Four (2%) of 162 patients were excluded from the intensive target group and two (1%) of 162 from the standard target group for withdrawal of consent or legal reasons. The mean systolic blood pressure during the first 24 h after reperfusion was 128 mm Hg (SD 11) in the intensive target group and 138 mm Hg (17) in the standard target group. The primary outcome was observed in 65 (42%) of 154 patients in the intensive target group and 68 (43%) of 157 in the standard target group on brain CT within 24-36 h after reperfusion] (adjusted odds ratio 0·96, 95% CI 0·60-1·51; p=0·84). Hypotensive events were not significantly different between both groups and occurred in 12 (8%) of 158 patients in the intensive target and five (3%) of 160 in the standard target group. Mortality within the first week after randomisation occurred in 11 (7%) of 158 patients in the intensive target group and in seven (4%) of 160 in the standard target group.An intensive systolic blood pressure target of 100-129 mm Hg after successful endovascular therapy did not reduce radiographic intraparenchymal haemorrhage rates at 24-36 h as compared with a standard care systolic blood pressure target of 130-185 mm Hg. Notably, these results are applicable to patients with successful reperfusion and systolic blood pressures of more than 130 mm Hg at the end of procedure. Further studies are needed to understand the association between blood pressure and outcomes after reperfusion.French Health Ministry.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Garfield完成签到 ,获得积分10
刚刚
Nosevaya完成签到 ,获得积分10
1秒前
wxnice完成签到,获得积分10
1秒前
小徐完成签到 ,获得积分10
1秒前
柿子完成签到,获得积分10
1秒前
LEO2025完成签到 ,获得积分10
1秒前
livra1058完成签到,获得积分10
1秒前
夕阳完成签到 ,获得积分10
2秒前
积极的白羊完成签到 ,获得积分10
2秒前
吴老师完成签到 ,获得积分10
3秒前
3秒前
yyyes1202完成签到 ,获得积分10
4秒前
沐野完成签到 ,获得积分10
4秒前
Wells发布了新的文献求助30
6秒前
hdc12138完成签到,获得积分10
8秒前
8秒前
CowPageant完成签到,获得积分10
10秒前
搬砖吗喽完成签到,获得积分10
10秒前
11秒前
卞卞完成签到,获得积分10
13秒前
致杨仔完成签到 ,获得积分10
13秒前
哭泣振家完成签到,获得积分10
14秒前
dididi完成签到 ,获得积分10
14秒前
zheng发布了新的文献求助30
15秒前
parantal发布了新的文献求助30
15秒前
顾旻完成签到 ,获得积分10
18秒前
不安丹云完成签到,获得积分10
20秒前
着急的冷珍完成签到,获得积分10
20秒前
阳佟半双完成签到,获得积分10
22秒前
Th完成签到 ,获得积分10
23秒前
h11的应助被科研通管家采纳,获得10
26秒前
26秒前
脑洞疼的应助被科研通管家采纳,获得10
26秒前
26秒前
桐桐的应助被科研通管家采纳,获得30
26秒前
俊逸寻雪完成签到,获得积分10
26秒前
Maestro_S的应助被科研通管家采纳,获得30
26秒前
嫁个养熊猫的完成签到 ,获得积分10
27秒前
易道聚焦完成签到,获得积分10
28秒前
耍酷的冷雪完成签到,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173347
求助须知:如何正确求助?哪些是违规求助? 9565632
关于积分的说明 21780648
捐赠科研通 7767505
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555841
邀请新用户注册赠送积分活动 2476749